<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The clinical, laboratory, and pathological features of <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> of the central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) were studied in a series of 17 autopsied patients </plain></SENT>
<SENT sid="1" pm="."><plain>Two groups were defined </plain></SENT>
<SENT sid="2" pm="."><plain>Group A consisted of 8 patients with diseases commonly associated with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e>: <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, and renal transplantation </plain></SENT>
<SENT sid="3" pm="."><plain>Group B contained 9 patients with various illnesses not generally known to be associated with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> was diagnosed and treated before <z:hpo ids='HP_0011420'>death</z:hpo> in only 1 patient </plain></SENT>
<SENT sid="5" pm="."><plain>Patients in Group A received cytotoxic drugs, often had <z:hpo ids='HP_0001913'>granulocytopenia</z:hpo>, less commonly had focal neurological deficits, and seldom had <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Group B patients were not granulocytopenic, received no cytotoxic agents, underwent nontransplant surgery, and more frequently had focal neurological deficits </plain></SENT>
<SENT sid="7" pm="."><plain>Eleven of the 17 patients (65%) had focal deficits, most of them <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Meningeal signs were rare, but the cerebrospinal fluid was usually abnormal </plain></SENT>
<SENT sid="9" pm="."><plain>The principal neuropathological process was Aspergillus invasion of blood vessels causing hemorrhagic infarction </plain></SENT>
<SENT sid="10" pm="."><plain>Focal clinical deficits correlated neuroanatomically with Aspergillus lesions </plain></SENT>
<SENT sid="11" pm="."><plain>In 2 patients, such lesions were detected by 99mTc-<z:chebi fb="0" ids="35739">DTPA</z:chebi> or cerebral angiography before computed tomographic scanning </plain></SENT>
<SENT sid="12" pm="."><plain>The lungs were the usual portal of entry, but isolated <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> lesions occurred in 2 patients </plain></SENT>
<SENT sid="13" pm="."><plain><z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> should be considered as a cause of new <z:hpo ids='HP_0003674'>onset</z:hpo> of focal neurological deficits in patients with illnesses that are more diverse than has generally been appreciated </plain></SENT>
</text></document>